HBM Healthcare Investments AG

HBMN:SWX

HBM Healthcare Investments AG

Actions
  • Price (CHF)181.40
  • Today's Change-0.20 / -0.11%
  • Shares traded6.71k
  • 1 Year change+7.59%
  • Beta0.9541
Data delayed at least 15 minutes, as of Nov 06 2024 16:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CHFIncome statement in CHFView more

Year on year HBM Healthcare Investments AG grew revenues -- from -117.56m to 23.19m while net income improved from a loss of 146.32m to a smaller loss of 1.08m.
Gross margin80.72%
Net profit margin79.66%
Operating margin80.75%
Return on assets4.99%
Return on equity5.54%
Return on investment5.23%
More ▼

Cash flow in CHFView more

In 2024, HBM Healthcare Investments AG increased its cash reserves by 78.42%, or 4.50m. Cash Flow from Investing totalled 125.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.71m for operations while cash used for financing totalled 118.80m.
Cash flow per share--
Price/Cash flow per share--
Book value per share244.34
Tangible book value per share244.34
More ▼

Balance sheet in CHFView more

HBM Healthcare Investments AG has a Debt to Total Capital ratio of 5.64%, a lower figure than the previous year's 6.02%.
Current ratio0.0776
Quick ratio--
Total debt/total equity0.0598
Total debt/total capital0.0564
More ▼

Growth rates in CHF

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 99.26%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)3.49%
Div growth rate (5 year)0.00%
Payout ratio (TTM)56.88%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
151.16
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.